Head and Neck Cancer Trial, Recruiting (NCT02572778)

Head and Neck Cancer Trial, Recruiting NCT02572778 Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02572778 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with head and neck cancer for the first time, or whose cancer has come back or spread to other parts of the body.
People who are about to have surgery or a tissue sample (biopsy) taken from their tumour.
People whose medical records include details about their cancer stage, type, any treatments received, how the cancer responded to treatment, and whether it has returned.
People for whom follow-up medical information is available after treatment.
People whose cancer has returned are also eligible to be considered.
People who have given written agreement (informed consent) to take part in the trial.

Who may not be able to join:

No specific exclusion criteria were listed in the official trial information (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Pascal Machiels, MD, PhD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phone: 00322764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02572778

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 00322764

More information: https://clinicaltrials.gov/study/NCT02572778

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with head and neck cancer for the first time, or whose cancer has come back or spread to other parts of the body.
People who are about to have surgery or a tissue sample (biopsy) taken from their tumour.
People whose medical records include details about their cancer stage, type, any treatments received, how the cancer responded to treatment, and whether it has returned.
People for whom follow-up medical information is available after treatment.
People whose cancer has returned are also eligible to be considered.
People who have given written agreement (informed consent) to take part in the trial.

Who may not be able to join:

No specific exclusion criteria were listed in the official trial information (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Registry

ClinicalTrials.gov

Start date

1 September 2015

Est. completion

1 December 2025

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Identification of the biomarkers of new cancer therapies for head and neck cancer on the patient-derived xenografts with immunohistochemistry (KI67) on FFPE (fixation followed by paraffin embedding) slides

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov